Sickle cell disease (SCD) is a group of blood conditions that affect hemoglobin, the part of red blood cells that delivers oxygen to cells in the body. In the United States, most people with SCD are of African or Hispanic heritage. However, the disease can affect anyone, especially people of southern European, Middle Eastern or Asian Indian heritage.
Seattle Children’s and Odessa Brown Children’s Clinic (OBCC) team have been treating patients with SCD for more than two decades. In that time, many lessons have been learned and as a result a new integrated Center of Excellence has been created for the care of patients with SCD at the hospital campus and at OBCC Othello, led by the Cancer and Blood Disorders Center and OBCC. As part of this Center of Excellence, a roadmap of program enhancements are in place to make progress towards improving and growing the Seattle Children’s Sickle Cell Disease Program to better serve patients with SCD and their families.